Status | Study |
Recruiting |
Study Name: A Study of Atezolizumab Versus Placebo in Combination With Paclitaxel, Carboplatin, and Bevacizumab in Participants With Newly-Diagnosed Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Date: 2017-01-30 Interventions: Drug: Paclitaxel Paclitaxel 17 |
Recruiting |
Study Name: PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer Condition: Ovarian Cancer Fallopian Tube Cancer Date: 2015-10-06 Interventions: Drug: Olaparib Olaparib starts |
Completed |
Study Name: Consumer-Based Activity Monitor in Evaluating and Measuring Activity of Older Patients With Abdominal Cancer Undergoing Surgery Condition: Malignant Gastrointestinal Neoplasm Malignant Peritoneal Neoplasm Date: 2015-01-29 Interventions: Device: Management of Therapy Complications Fitbit Zip (portable pedometer d |
Recruiting |
Study Name: Adjuvant HIPEC in High Risk Colon Cancer Condition: Colorectal Neoplasms Peritoneal Neoplasms Date: 2014-08-22 Interventions: Procedure: Adjuvant HIPEC (open/laparoscopic) |
Not yet recruiting |
Study Name: An Observational Study of Avastin (Bevacizumab) in Patients With Advanced/Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer Condition: Ovarian Cancer, Peritoneal Neoplasms Date: 2013-08-27 |
Completed |
Study Name: Goal Directed Therapy (GDT) in Cytoreductive Surgery (CRS) and Hyperthermic Intra Peritoneal Chemotherapy (Hipec) Condition: Primary Peritoneal Neoplasm Secondary Per Date: 2013-06-10 Interventions: Drug: Goal Directed Intravenous Restrictive Fluid Therapy |
Active, not recruiting |
Study Name: BOVARI: A Non-Interventional Study of Avastin (Bevacizumab) as Front-Line Treatment in Patients With Ovarian Cancer Condition: Ovarian Cancer, Peritoneal Neoplasms Date: 2013-02-08 |
Recruiting |
Study Name: An Observational Study of Avastin (Bevacizumab) in Combination With Carboplatin/Paclitaxel in First Line in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (OTILIA) Condition: Peritoneal Neoplasms Date: 2012-09-28 |
Completed |
Study Name: BIBF 1120 + Carboplatin/Pegylated Liposomal Doxorubicin (PLD) in Patients With Advanced Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Cancer Condition: Ovarian Neoplasms Peritoneal Neoplasms Date: 2011-03-08 Interventions: Drug: BIBF 1120 + PLD 30 mg/m2 + CBDCA AUC5 mg/mL*min |
Withdrawn |
Study Name: Comparison of Traditional and Echocardiography Guided Fluid Management During Cytoreductive Surgery With HIPEC Condition: Peritoneal Neoplasms Echocardiography Guided Fluid Management Date: 2010-07-14 Interventions: Device: Echocardiogram Echocardiography will be utilized during the procedure to guide fluid management. |